Splinter Cell returns 11 years later with promising Netflix adaptation
It's not a new game but Netflix's promising Deathwatch show could be just what Ubisoft's forgotten franchise needs.
The EMBO Journal1d
Astrocyte allocation during brain development is controlled by Tcf4-mediated fate restriction
Astrocytes in the brain exhibit significant regional diversity, but the mechanisms controlling their heterogeneity remain ...
technologynetworks2d
How Epigenetic Marks Influence Stem Cell Function and Fate
A study uncovers how histone modifications, specifically in the H3.3 protein, regulate gene expression in mouse stem cells.
FierceBiotech1d
From 'science fiction to reality': New George Church-founded biotech raises $75M for cell therapy platform
“This approach harnesses the transformative potential of transcription factor biology to guide iPSC cell fate into any ...
Business Wire1d
GC Therapeutics Launches to Scale and Unlock the Next Generation of Cell Therapy
“This approach harnesses the transformative potential of transcription factor biology to guide iPSC cell fate into any differentiated cell type in a single, seamless step. By transcending the ...
Fate Therapeutics to Present at 2024 Cantor Global Healthcare Conference
SAN DIEGO, Sept. 12, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to ...
Why Is Fate Therapeutics (FATE) Up 18.7% Since Last Earnings Report?
Fate Therapeutics (FATE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Yahoo Finance7d
Why Is Fate Therapeutics (FATE) Up 18.7% Since Last Earnings Report?
Fate is focused on the development and manufacture of universal, off-the-shelf cell products using its proprietary induced pluripotent stem cell (iPSC) product platform. Its immuno-oncology ...